The Efficacy of Gliatiline® on Post-stroke Patients With Vascular Cognitive Impairment no Dementia

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 222 participants.

Also called NCT01363648

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 222 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01363648
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01363648. Randomized; quadruple masking; primary purpose treatment. Start 2010-11 (registry gives no type); primary completion 2013-03 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Efficacy of Gliatiline® on Post-stroke Patients With Vascular Cognitive Impairment no Dementia
Acronym
GLITTER
Condition
Cognitive Impairment
Condition
Stroke
Intervention (Drug)
choline alfoscerate
Intervention (Drug)
placebo (for choline alphoscerate)
Lead sponsor
Seoul National University Hospital (class: other)

Record details

Record id
cardio:ct-nct01363648
Content hash
5bc3540da8bb816b1ea4740c65872c64dcc666fed58cbbc3680f7e857e2451ee